Angiotensin II type 1/adenosine A 2A receptor oligomers: a novel target for tardive dyskinesia

Angiotensin II type 1/adenosine A 2A receptor oligomers: a novel target for tardive dyskinesia

Abstract Tardive dyskinesia (TD) is a serious motor side effect that may appear after long-term treatment with neuroleptics and mostly mediated by dopamine D2 receptors (D2Rs). Striatal D2R functioning may be finely regulated by either adenosine A2A receptor (A2AR) or angiotensin receptor type 1 (AT...

Full description

Bibliographic Details
Main Authors:	Paulo A. de Oliveira, James A. R. Dalton, Marc López-Cano, Adrià Ricarte, Xavier Morató, Filipe C. Matheus, Andréia S. Cunha, Christa E. Müller, Reinaldo N. Takahashi, Víctor Fernández-Dueñas, Jesús Giraldo, Rui D. Prediger, Francisco Ciruela
Format:	Article
Language:	English
Published:	Nature Portfolio 2017-05-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-017-02037-z

Similar Items

Tardive dyskinesia
by: Violetta A. Tolmacheva
Published: (2021-11-01)

Tardive Dyskinesia and Treatment Approaches
by: Mehmet Emin Demirkol, et al.
Published: (2018-06-01)

Improvement of Tardive Dyskinesias with Olanzapine
by: S. Echater, et al.
Published: (2023-01-01)

Drug-induced tardive dyskinesia
by: T. M. Ostroumova, et al.
Published: (2020-02-01)

Reversibility of Tardive Dyskinesia Syndrome
by: Angel Vinuela, et al.
Published: (2014-12-01)

Amisulpride Reexposure and Tardive Dyskinesia
by: Ajeet Sidana
Published: (2018-01-01)

Lurasidone-induced tardive dyskinesia
by: Shreyas Shrikant Pendharkar, et al.
Published: (2022-01-01)

Olanzapine induced tardive dyskinesia
by: Rudraprosad Chakraborty, et al.
Published: (2014-01-01)

Facial mask masking tardive dyskinesia
by: I. Ganhao
Published: (2021-04-01)

Pathophysiology, prognosis and treatment of tardive dyskinesia
by: Hiroyoshi Takeuchi, et al.
Published: (2022-10-01)

Clinical Diagnosis and Treatment of Tardive Dyskinesia
by: WANG Xixi, et al.
Published: (2022-07-01)

Improvement of Tardive Dyskinesia during Mindfulness Meditation
by: Maria Angela Santoro, et al.
Published: (2021-08-01)

Deep Brain Stimulation in the Treatment of Tardive Dyskinesia
by: Adrianna Szczakowska, et al.
Published: (2023-02-01)

A case of tardive dyskinesia with paliperidone palmitate
by: Philip Kumar Boyanapally, et al.
Published: (2015-01-01)

Genome wide study of tardive dyskinesia in schizophrenia
by: Lim, Keane, et al.
Published: (2022)

Tardive dyskinesia on clozapine: A case report
by: Laila Asmal
Published: (2009-03-01)

Tardive dyskinesia in an 8-year old child
by: W. M.M.L. Chandradasa, et al.
Published: (2014-12-01)

Tardive dyskinesia: Prevention and newer management strategies
by: Sreelakshmi Vaidyanathan, et al.
Published: (2020-01-01)

An Update on Tardive Dyskinesia: From Phenomenology to Treatment
by: Olga Waln, et al.
Published: (2013-07-01)

5-Hydroxytryptamine Receptors and Tardive Dyskinesia in Schizophrenia
by: Ivan V. Pozhidaev, et al.
Published: (2020-04-01)

A case of levosulpiride-induced tardive dyskinesia
by: Soumitra Ghosh, et al.
Published: (2019-06-01)

Relevance of animal models to human tardive dyskinesia
by: Blanchet Pierre J, et al.
Published: (2012-03-01)

Tardive Dyskinesia in Older Persons Taking Antipsychotics
by: Citrome L, et al.
Published: (2021-10-01)

The Tardive Dyskinesia Impact Scale (TDIS), a novel patient-reported outcome measure in tardive dyskinesia: development and psychometric validation
by: Robert H. Farber, et al.
Published: (2024-01-01)

Spontaneous orofacial dyskinesias in a captive cynomolgus monkey: implications for tardive dyskinesia.
by: Rupniak, N, et al.
Published: (1990)

Pimozide-induced tardive dyskinesia in the treatment of delusions of infestation
by: Rodrigo A. Gutierrez, BS, et al.
Published: (2024-03-01)

Genes of the Glutamatergic System and Tardive Dyskinesia in Patients with Schizophrenia
by: Olga Yu. Fedorenko, et al.
Published: (2022-06-01)

Putative role of immune reactions in the mechanism of tardive dyskinesia
by: Anton J.M. Loonen
Published: (2023-11-01)

Pathophysiological mechanisms underlying antipsychotic-induced tardive dyskinesia
by: E. E. Vayman, et al.
Published: (2020-01-01)

Tardive dyskinesia: understanding current challenges in diagnosis and treatment
by: David Taylor, et al.
Published: (2023-01-01)

Genetic Susceptibility to Tardive Dyskinesia and Cognitive Impairments in Chinese Han Schizophrenia: Role of Oxidative Stress-Related and Adenosine Receptor Genes
by: Jiang Q, et al.
Published: (2023-11-01)

Impact of a pharmacist-driven tardive dyskinesia screening service
by: Niyati Butala, PharmD, BCPP, et al.
Published: (2021-07-01)

Improvement of tardive dyskinesia in a depressive patient treated with fluvoxamine
by: G. Dzhupanov
Published: (2023-03-01)

Treatment of tardive dyskinesias with vitamin E: A case series
by: B. Senol, et al.
Published: (2023-03-01)

An investigation on the relationship between risk factors and severity of tardive dyskinesia
by: Y Kalafi, et al.
Published: (1993-12-01)

A systematic review on treatment of tardive dyskinesia with valbenazine and deutetrabenazine
by: Rikinkumar S. Patel, et al.
Published: (2019-05-01)

Scopolamine alleviates involuntary lingual movements: tardive dyskinesia or dystonia?
by: Hu JB, et al.
Published: (2017-08-01)

Digital functionally generated path technique in a tardive dyskinesia patient
by: A/Prof Du Hyeong Lee, et al.
Published: (2023-09-01)

A Survey of the Tardive Dyskinesia Induced by Antipsychotic Drugs in Patients with Schizophrenia
by: Naser tabibi, et al.
Published: (2010-11-01)

Systematic review of interventions for treating or preventing antipsychotic-induced tardive dyskinesia
by: Hanna Bergman, et al.
Published: (2017-08-01)